Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.29−0.08 (-5.84%)
Close on Nov 18, 2026Market cap $97.08MP/E –Yield –
Health Catalyst revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Health Catalyst's revenue for the twelve months ending Jun 30, 2026 was $292.25M, down 7.5% year over year. For fiscal 2025 it was $311.14M, up 1.5% from the year before. The highest annual figure on record is $311.14M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $311.14M | +1.5% |
| FY2024 | Dec 31, 2024 | $306.58M | +3.6% |
| FY2023 | Dec 31, 2023 | $295.94M | +7.1% |
| FY2022 | Dec 31, 2022 | $276.24M | +14.2% |
| FY2021 | Dec 31, 2021 | $241.93M | +28.1% |
| FY2020 | Dec 31, 2020 | $188.85M | +21.9% |
| FY2019 | Dec 31, 2019 | $154.94M | +37.6% |
| FY2018 | Dec 31, 2018 | $112.57M | +54.0% |
| FY2017 | Dec 31, 2017 | $73.08M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $70.49M | -12.7% |
| Q1 FY2026 | Mar 31, 2026 | $70.76M | -10.9% |
| Q4 FY2025 | Dec 31, 2025 | $74.68M | -6.2% |
| Q3 FY2025 | Sep 30, 2025 | $76.32M | -0.0% |
| Q2 FY2025 | Jun 30, 2025 | $80.72M | +6.3% |
| Q1 FY2025 | Mar 31, 2025 | $79.41M | +6.3% |
| Q4 FY2024 | Dec 31, 2024 | $79.61M | +6.0% |
| Q3 FY2024 | Sep 30, 2024 | $76.35M | +3.5% |
| Q2 FY2024 | Jun 30, 2024 | $75.90M | +3.7% |
| Q1 FY2024 | Mar 31, 2024 | $74.72M | +1.2% |
| Q4 FY2023 | Dec 31, 2023 | $75.08M | +8.6% |
| Q3 FY2023 | Sep 30, 2023 | $73.77M | +7.9% |
| Q2 FY2023 | Jun 30, 2023 | $73.21M | +3.7% |
| Q1 FY2023 | Mar 31, 2023 | $73.87M | +8.5% |
| Q4 FY2022 | Dec 31, 2022 | $69.16M | +6.9% |
| Q3 FY2022 | Sep 30, 2022 | $68.35M | +10.7% |
| Q2 FY2022 | Jun 30, 2022 | $70.63M | +18.5% |
| Q1 FY2022 | Mar 31, 2022 | $68.09M | +21.9% |
| Q4 FY2021 | Dec 31, 2021 | $64.72M | +21.5% |
| Q3 FY2021 | Sep 30, 2021 | $61.74M | +30.8% |
| Q2 FY2021 | Jun 30, 2021 | $59.63M | +37.8% |
| Q1 FY2021 | Mar 31, 2021 | $55.85M | +23.8% |
| Q4 FY2020 | Dec 31, 2020 | $53.28M | +22.5% |
| Q3 FY2020 | Sep 30, 2020 | $47.19M | +19.7% |
| Q2 FY2020 | Jun 30, 2020 | $43.26M | +17.5% |
| Q1 FY2020 | Mar 31, 2020 | $45.12M | +28.1% |
| Q4 FY2019 | Dec 31, 2019 | $43.50M | +20.6% |
| Q3 FY2019 | Sep 30, 2019 | $39.42M | +19.9% |
| Q2 FY2019 | Jun 30, 2019 | $36.80M | +60.1% |
| Q1 FY2019 | Mar 31, 2019 | $35.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $36.08M | – |
| Q3 FY2018 | Sep 30, 2018 | $32.87M | – |
| Q2 FY2018 | Jun 30, 2018 | $22.99M | – |
See a number that looks wrong?